| |
|
|
|
| Unsafe Drugs
:: Avandia
|
AVANDIA - Avandia has been linked to heart attacks, congestive heart failure, liver damage, kidney problems, and increased bone thinning in both men and women. The diabetes drug, manufactured by pharmaceutical giant GlaskoSmithKline (NYSE: GSK), is under increased scrutiny leading concerned citizens to call for the FDA to ban the drug. Unfortunately, the drug is causing more problems than it is worth.
If you have been prescribed Avandia to treat diabetes and you have suffered from congestive heart failure or a heart attack, you need to contact an attorney. The prescription may have been for Avandia, Avandamet, or Avandaryl, which are alternate forms of Avandia. In addition, long term exposure by women has led to osteoporosis, increasing propensity for bone fractures and disabilities.
Unsafe drug cases are complex and costly to litigate. Experienced representation is essential, and that is exactly what we help provide. If you believe you or a loved one suffered a serious complication as a result of taking Avandia, please fill out the form below for a free evaluation.
Keywords: Avandia Lawsuit | Avandia Lawyer | Avandia Attorney | Avandia Lawyers | Avandia Attorneys
|
| Free Case Evaluation |
Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.
|
| Avandia In the News |
Actos, Avandia Linked to Fractures: Study - AboutLawsuits.com
TopNews Arab EmiratesActos, Avandia Linked to Fractures: StudyAboutLawsuits.comThe FDA added a “black box” warning in 2007 regarding the risk of heart attacks from Avandia, which some experts estimated could be responsible...
More Information »
AM Vitals: FDA Halts New Enrollment in Avandia-Actos Trial - Wall Street Journal (blog)
Washington PostAM Vitals: FDA Halts New Enrollment in Avandia-Actos TrialWall Street Journal (blog)FDA Says “Halt”: A study by GlaxoSmithKline comparing its diabetes drug Avandia to a rival drug, Actos, has stopped enrolling...
More Information »
Glaxo Rival Paid Fees to Doctor Who Voted Against Avandia - Wall Street Journal
dBTechnoGlaxo Rival Paid Fees to Doctor Who Voted Against AvandiaWall Street JournalDr. Capuzzi said in an interview that he hasn't given talks to doctors promoting Avandia but spoke on behalf of a different Glaxo drug....
More Information »
Avandia, GSK, FDA, Angels & Demons - WebMD (blog)
The GuardianAvandia, GSK, FDA, Angels & DemonsWebMD (blog)Graham's study suggested that Avandia is a much more dangerous choice. But as a counterpoint, FDA drug evaluation officers went over clinical trial data in...
More Information »
Investigation Launched into Conflict on Avandia Panel - AboutLawsuits.com
Investigation Launched into Conflict on Avandia PanelAboutLawsuits.comFDA officials said they were unaware at the time of the vote that Capuzzi had spoken for GlaxoSmithKline in any capacity. Avandia has come under harsh...
More Information »
GlaxoSmithKline Review Supports Avandia, FDA To Review Data - Wall Street Journal
GlaxoSmithKline Review Supports Avandia, FDA To Review DataWall Street JournalLN), a global healthcare group, said Friday its review supports the overall positive benefit-risk profile of Avandia (rosiglitazone maleate) as an...
More Information »
Avandia's future murky after FDA panel vote - American Medical News
Straits TimesAvandia's future murky after FDA panel voteAmerican Medical NewsThe FDA first put a black-box warning on Avandia (rosiglitazone) in 2007, when research came to light that GlaxoSmithKline's type 2 diabetes...
More Information »
Another FDA Advisory Panel Meeting: This Time, It's Avastin - Wall Street Journal (blog)
CBS NewsAnother FDA Advisory Panel Meeting: This Time, It's AvastinWall Street Journal (blog)Last week was a big one for high-profile FDA advisory panel meetings, with GlaxoSmithKline's diabetes drug Avandia and...
More Information »
Fero Industries Comments on Recent FDA Advisory Panel Recommendation on Avandia(R) - MarketWatch (press release)
Fero Industries Comments on Recent FDA Advisory Panel Recommendation on Avandia(R)MarketWatch (press release)The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the US market despite data...
More Information »
FDA Panel Votes to Restrict Avandia - New York Times
FDA Panel Votes to Restrict AvandiaNew York TimesDr. Sanjay Kaul, who voted to require stronger warnings, said that the FDA must ensure that Avandia was used far less regularly. ...
More Information »
FDA panel's vote on Avandia reveals mixed opinions on diabetes drug's safety - Washington Post
FDA panel's vote on Avandia reveals mixed opinions on diabetes drug's safetyWashington PostFDA Commissioner Margaret A. Hamburg will make the final decision about Avandia's future. Hamburg has pledged to make drug...
More Information »
FDA Scientists Debate Results Of Glaxo Avandia Study - Wall Street Journal
FDA Scientists Debate Results Of Glaxo Avandia StudyWall Street JournalAvandia is currently being reviewed by a federal panel that is scheduled to vote Wednesday on whether it thinks Avandia should remain on the US market....
More Information »
Avandia Raises Heart Risk, FDA Panel Finds - BusinessWeek
Avandia Raises Heart Risk, FDA Panel FindsBusinessWeekBut Garratt also said he didn't think the experts' votes would end the controversy over Avandia. "There is so much dissent within the FDA about the ...
More Information »
FDA Panel Votes to Restrict Avandia - New York Times (blog)
New York Times (blog)FDA Panel Votes to Restrict AvandiaNew York Times (blog)Dr. Woodcock decided in 2007 to keep Avandia on the market, and FDA safety officers who have advocated for Avandia's withdrawal blame her for...
More Information »
Ira Loss Sees `Mixed Decision' on Avandia by FDA Panel: Video - Washington Post
Washington PostIra Loss Sees `Mixed Decision' on Avandia by FDA Panel: VideoWashington PostThe FDA advisory panel decided today that Avandia increases the risk of cardiovascular side effects. The panel meeting in...
More Information »
FDA panel backs Avandia although concerns linger - Boston Globe
Boston GlobeFDA panel backs Avandia although concerns lingerBoston GlobeUS doctors prescribed Avandia about 2 million times in 2009. The debate hinged on what standard of proof the FDA should use to justify removing a drug...
More Information »
FDA Panel Recommends Restricting Avandia - ABC News
ABC NewsFDA Panel Recommends Restricting AvandiaABC News"Today, the risk clearly outweighs the benefits in Rosi [Avandia]," panel member Dr. Curt Furberg said. "The benefit is modest at best. ...
More Information »
Avandia Bares Changing FDA - WebMD (blog)
Avandia Bares Changing FDAWebMD (blog)“The key question is whether the FDA review uncovered deliberate attempts to cover up harm from [Avandia]. Is it malfeasance?” Kaul asked. ...
More Information »
Avandia, Qnexa Mean a Big Week for FDA Advisory Committee - Wall Street Journal (blog)
Avandia, Qnexa Mean a Big Week for FDA Advisory CommitteeWall Street Journal (blog)The FDA's advisory committee on endocrinologic and metabolic drugs has a busy week. Tomorrow and Wednesday it will consider Avandia, ...
More Information »
How the FDA Panel's Votes on Avandia Went Down - Wall Street Journal (blog)
How the FDA Panel's Votes on Avandia Went DownWall Street Journal (blog)And the biggie: Based on all the available data, what should the FDA do about Avandia? A. Allow continued marketing, revise current label to remove...
More Information »
More Questions About Avandia - New York Times (blog)
Newsome Law (blog)More Questions About AvandiaNew York Times (blog)The FDA has compelled Glaxo to sponsor a large randomized clinical trial, the gold standard, that will test the cardiovascular effects of both Avandia and...
More Information »
IN HEALTH TODAY Johns Hopkins helps FDA in its review of problem drugs - Baltimore Sun
Baltimore SunIN HEALTH TODAY Johns Hopkins helps FDA in its review of problem drugsBaltimore SunThe agency should also ensure post-market trials should minimize the risk to patients and monitor ongoing risks, and the FDA...
More Information »
Glaxo inches up ahead of FDA meeting - MarketWatch
Glaxo inches up ahead of FDA meetingMarketWatchA joint advisory panel of the US Food and Drug Administration will discuss whether there is enough evidence to show that Avandia poses a significant ...and more »
More Information »
Vivus shares fall ahead of review for obesity drug - BusinessWeek
Vivus shares fall ahead of review for obesity drugBusinessWeek... of the FDA's panel of endocrinology specialists. Wedbush Securities analyst Michael King says investors are questioning whether the Avandia debate will...
More Information »
Safety of diabetes drug Avandia debated by federal scientists - Washington Post
Safety of diabetes drug Avandia debated by federal scientistsWashington PostSales of Avandia plummeted, and the FDA issued strong new warnings about the drug's safety. But after a panel of advisers voted later that year...
More Information »
Close the FDA Approval Gap - Huffington Post (blog)
Close the FDA Approval GapHuffington Post (blog)... the safety of Avandia since 2007, and a process to assess these risks versus patient benefits was undertaken by the objective professionals at FDA. ...FDA Criticized for...
More Information »
Avandia shows need for stronger FDA - DesMoinesRegister.com
Avandia shows need for stronger FDADesMoinesRegister.comThat is the question millions of Type 2 diabetics have been asking about Avandia, a prescription drug used to control blood sugar levels. ...and more »
More Information »
FDA advisory panel may make recommendation on safety of diabetes drug Avandia ... - Boston Globe
FDA advisory panel may make recommendation on safety of diabetes drug Avandia ...Boston Globe(Avandia) increases the risk'' for heart attack. Unger alluded to the disagreements between FDA officials in his remarks...
More Information »
Avandia: A New Day For FDA Or 'Groundhog Day' - NPR (blog)
Avandia: A New Day For FDA Or 'Groundhog Day'NPR (blog)FDA advisors were distressed to hear that, due in part to the cloud over Avandia, only about 1100 of the hoped-for 16000 TIDE volunteers have signed up, ...
More Information »
Diabetes Drug Avandia Gets Pass From FDA Panel - NPR (blog)
Diabetes Drug Avandia Gets Pass From FDA PanelNPR (blog)Avandia got a pass from an FDA advisory panel which recommended the diabetes drug stay on the market despite concerns that it raises ...
More Information »
The Avandia Controversy - WebMD (blog)
The Avandia ControversyWebMD (blog)This week, the FDA will consider outlawing Avandia. In the meantime, patients who take Avandia are advised to discuss their options with their prescribing ...Avandia decision could bolster...
More Information »
Avandia Hearings to Reveal True Dangers of Popular Drug - FOXNews
Avandia Hearings to Reveal True Dangers of Popular DrugFOXNewsAvandia and Actos are both pills that help the body make better use of insulin, a key digestive hormone. The study by the FDA that put GlaxoSmithKilne under ...
More Information »
Avandia Advice: Talk to Your Doctor. (But What About?) - Wall Street Journal (blog)
Avandia Advice: Talk to Your Doctor. (But What About?)Wall Street Journal (blog)The Avandia case is particularly tricky, because the FDA panel's vote can be interpreted in so many ways. “You can't just send people to...
More Information »
One Sign FDA Could Pull Avandia - Forbes (blog)
One Sign FDA Could Pull AvandiaForbes (blog)... the patient representative on the trial and a diabetic, noted that she had recommended to her mother, a heart patient, that she should not take Avandia.and more »
More Information »
Arena Pharma Rallies On FDA Optimism; Vivus Shares Halted - Wall Street Journal
Arena Pharma Rallies On FDA Optimism; Vivus Shares HaltedWall Street JournalAlso boosting Arena shares was a Wednesday FDA panel meeting convened to discuss the cardiovascular risks posed by Avandia, a leading diabetes drug...
More Information »
The Avandia Saga Continues - New York Times (blog)
The Avandia Saga ContinuesNew York Times (blog)The evidence, however, is mixed, and one recent study even suggested that Avandia might lower some cardiovascular risks. The FDA's own staff is sharply ...
More Information »
FDA panel in favor of keeping Avandia on the market - TIME (blog)
FDA panel in favor of keeping Avandia on the marketTIME (blog)Despite concerns that the popular GlaxoSmithKline diabetes drug Avandia could raise the risk for heart attack, a Food and Drug Administration (FDA) advisory ...
More Information »
Avandia Heart Risks Buried by Drug Company: Report - BusinessWeek
Avandia Heart Risks Buried by Drug Company: ReportBusinessWeek... some cardiovascular effects of Avandia. The official's posting was part of a safety reassessment package prepared for the FDA's advisory panel meeting....
More Information »
FDA panel recommends keeping Avandia on market - MarketWatch
FDA panel recommends keeping Avandia on marketMarketWatchIn February, the FDA sent letters to doctors and patients that it was reviewing study data showing the connection between Avandia and myocardial ischemia, ...
More Information »
Avandia News: What You Need to Know - CBS News
Avandia News: What You Need to KnowCBS NewsAnalysts expected the company could have shouldered as much as $6 billion if the FDA took Avandia off the market, according to the Wall Street Journal. ...
More Information »
Avandia controversy shows rift in FDA ranks - Salt Lake Tribune
Avandia controversy shows rift in FDA ranksSalt Lake TribuneAs the FDA began a two-day meeting Tuesday to discuss Avandia's future, it became clear the agency's own scientists are deeply divided. ...
More Information »
Don't dump Avandia, diabetes groups urge patients - Reuters
Don't dump Avandia, diabetes groups urge patientsReutersMembers of the FDA advisory panel disagreed on whether studies on Avandia provided strong enough evidence to merit taking it off the market. ...
More Information »
Actos Ads Jump on Avandia Woes - New York Times (blog)
Actos Ads Jump on Avandia WoesNew York Times (blog)Takeda started the campaign for Actos the day after an FDA panel voted 20-12 to leave Avandia, from GlaxoSmithKline, on the market but with restrictions ...
More Information »
Doctors Face Difficult Decision On Prescribing Avandia - NPR
Doctors Face Difficult Decision On Prescribing AvandiaNPRA panel of experts voted Wednesday to recommend that the FDA keep the diabetes drug Avandia on the market despite findings that the drug increases the risk ...
More Information »
FDA Panel Rejects Obesity Drug Qnexa Over Less Safety Data - USANewsWeek.com
FDA Panel Rejects Obesity Drug Qnexa Over Less Safety DataUSANewsWeek.comAvandia came under FDA scanner after multiple studies said that Avandia elevated heart risks. A study was conducted on 3000 patients in this regard....
More Information »
What Now for the Diabetes Drug Avandia? - U.S. News & World Report
What Now for the Diabetes Drug Avandia?U.S. News & World ReportYet even with all the growing evidence—and the negative press and growing calls for Avandia to be yanked from the market—the FDA panel of outside experts ...
More Information »
FDA advisory panel recommends keeping Avandia on the market with additional ... - Examiner.com
Examiner.comFDA advisory panel recommends keeping Avandia on the market with additional ...Examiner.comAfter two days of hearings the 33 members of the FDA's advisory panel voted to allow Avandia to stay on the market....
More Information »
Diabetes Drug Avandia Should Stay on the Market, FDA Panelists Say - Food Consumer
Diabetes Drug Avandia Should Stay on the Market, FDA Panelists SayFood ConsumerAvandia was approved by the FDA years ago and evidence has ever since emerged to suggest that this drug indicated to treat diabetes patients to...
More Information »
FDA Panel Recommends Keeping Avandia On The Market - NY1
NY1FDA Panel Recommends Keeping Avandia On The MarketNY1Instead of taking Avandia off the market, the FDA issued a warning label for the product. Since then questions have emerged about whether the drug company ...
More Information »
FDA Panel Split On Avandia - RTT News
RTT NewsFDA Panel Split On AvandiaRTT News(RTTNews) - An FDA panel looking into the safety of GlaxoSmithKline's Avandia diabetes drug came away with mixed results on Wednesday. ...
More Information »
|
|
| |